omniture
logo
Search
Telix Pharma
Media Room

Latest News

rss

Illuccix® Granted Transitional Pass-Through Payment Status

INDIANAPOLIS, May 31, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Comp...

2022-05-31 19:00 1906

Illuccix® Reimbursement Milestone and Launch Updates: Pass-Through Status Granted in the U.S.

MELBOURNE, Australia and INDIANAPOLIS, May 30, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (...

2022-05-30 08:02 3765

First Patient Dosed in Phase II Renal Cancer Theranostics Study

MELBOURNE, Australia and INDIANAPOLIS, May 5, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (A...

2022-05-05 05:00 3203

Telix Further Strengthens European Distribution Network for Illuccix

MELBOURNE, Australia and LIÈGE, Belgium, April 22, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limit...

2022-04-22 07:10 4136

First Patients Dosed with Illuccix® - Telix's Approved Prostate Cancer Imaging Agent

Physicians in Indiana, New York City, and Washington are among the first to administer Illuccix® – ...

2022-04-14 19:00 3168

ProstACT Update: TARGET Study Ethics Approval

MELBOURNE, Australia, April 12, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix...

2022-04-12 07:47 1804

Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab

MELBOURNE, Australia and INDIANAPOLIS, April 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited...

2022-04-11 06:51 2540

PSMA-PET Imaging to be Funded through Medicare in Australia from July 2022

MELBOURNE, Australia, April 6, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix,...

2022-04-06 12:47 3798

Telix, GMS and Monash Awarded $23M Federal Government Funding as part of $71M Australian Precision Medicine Enterprise (APME) Project

MELBOURNE, Australia, April 4, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix,...

2022-04-04 09:13 4292

Commercial Launch: Illuccix® Now Available to Order in the United States

MELBOURNE, Australia and INDIANAPOLIS, April 4, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited ...

2022-04-04 07:06 3174

Change of Composition of the Telix Board of Directors

* Non-Executive Director Oliver Buck to retire at the Annual General Meeting * Tiffany Olson, ex...

2022-03-31 07:11 2876

New Video Series "PSMA PET/CT TODAY" Discusses the Future of Prostate Cancer Care with Leading Experts

MELBOURNE, Australia and INDIANAPOLIS, March 29, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited...

2022-03-29 19:00 2058

Telix Granted FDA Orphan Drug Designation for Bone Marrow Conditioning Treatment

MELBOURNE, Australia and INDIANAPOLIS, March 29, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited...

2022-03-29 13:34 2470

Telix and Xiel Sign U.K. and Ireland Distribution Agreement for Illuccix®

MELBOURNE, Australia and LIÈGE, Belgium, March 29, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limit...

2022-03-29 07:39 2601

Telix Advances Development of Glioblastoma Therapy Program

MELBOURNE, Australia, March 23, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix...

2022-03-23 10:16 2611
1 ... 678910